Home › Pathophysiology › Diabetic Neuropathy

Diabetic Neuropathy

*Neuropathia diabetica*

For medical students2 min readUpdated 2026-10-10

Diabetic neuropathy is traditionally considered a late complication of diabetes mellitus, although its initial symptoms can appear in the early stages of the disease. The pathology can affect virtually any part of the nervous system, and the severity of impairments directly correlates with the duration of chronic hyperglycemia and glycemic control.

Primary TriggerChronic hyperglycemia initiating a cascade of metabolic disturbances

Onset TimelineClassically a late complication, but symptoms may occur early

Pathogenetic BasisMetabolic disorders and impaired intraneural blood supply

Critical RiskAutonomic form threatens sudden cardiac death due to regulatory failure

Etiology and Key Pathogenetic Mechanisms

The triggering factor initiating the destruction of neural tissue is hyperglycemia. Elevated blood glucose levels provoke profound metabolic disorders and disrupt intraneural blood supply. These etiologic factors trigger four main pathogenetic mechanisms:

Excessive Glycosylation. Peripheral nerve proteins undergo non-enzymatic glycation, which disrupts their structure and normal function.
Autoimmune Component. Glycosylated proteins are recognized by the body as foreign. Specific immunoglobulins (Ig) are produced against these altered structures, leading to autoaggression directed at the body's own neural tissue antigens (Ag).
Activation of the Polyol (Sorbitol) Pathway. In neurons and Schwann cells, the enzyme aldose reductase is activated. It catalyzes the conversion of excess glucose into sorbitol. Accumulation of sorbitol causes cellular damage.
Chronic Ischemia. A critical reduction in intraneural blood flow occurs. Neural structures experience a constant deficit of oxygen, leading to hypoxia.

Classification of Clinical Manifestations

The clinical presentation of diabetic nervous system involvement is remarkably diverse. Depending on the localization of the pathological process, several main forms of the disease are distinguished. These include classic peripheral polyneuropathies affecting multiple nerve trunks. Autonomic neuropathies disrupting internal organ function are also identified. Radiculopathies (nerve root involvement) and mononeuropathies (isolated involvement of individual nerves) represent separate clinical forms.

Autonomic Manifestations

Involvement of the autonomic nervous system in diabetes leads to severe systemic failures. Autonomic neuropathies manifest in several critical areas:

Impaired Neurogenic Vascular Regulation. Patients develop positional (orthostatic) hypotensive reactions. A classic example is a sharp, acute drop in blood pressure upon changing body position (rising from a supine or sitting position), which frequently results in syncope.
Disordered Cardiac Regulation. This is one of the most dangerous manifestations, as it is associated with an extremely high risk of sudden cardiac death.
Sexual Dysfunction. Impairment of autonomic innervation predictably leads to reproductive and sexual disorders.

Radiculopathies and Mononeuropathies

In addition to peripheral polyneuropathies and autonomic disorders, diabetes frequently affects spinal nerve roots and individual peripheral or cranial nerves.

Radiculopathies arise due to structural changes directly within the spinal nerve roots. The clinical picture is characterized by pronounced pain radiating along the course of one or several spinal nerves. The preferred localization of such pain is the chest and abdominal wall. Hyperesthesia (increased sensitivity) is observed in these same zones.

Mononeuropathies are characterized by focal involvement affecting individual cranial nerves or proximal motor neurons. Clinically, this presents as transient flaccid paralysis of the hands and feet. Regarding cranial nerves, reversible paresis of the oculomotor (III), trochlear (IV), or abducens (VI) nerves is typical.

Mnemonic

To quickly remember the pathogenetic mechanisms, use the acronym GISA: Glycosylation, Ischemia, Sorbitol, Autoimmune reaction. All are triggered by hyperglycemia.

Frequently asked questions

What specific cardiac abnormalities occur in diabetic autonomic neuropathy?

In diabetic autonomic neuropathy, cardiovascular regulation abnormalities include:

disordered neural regulation of cardiac activity with a high risk of sudden death;
impaired neurogenic vascular tone regulation with positional (orthostatic) hypotensive reactions; syncope may occur due to an acute drop in blood pressure when rising from a supine or sitting position.

Additionally, silent myocardial infarction is noted as a clinical consequence of diabetic neuropathy.

What specific sensory disturbances are characteristic of classic distal symmetric polyneuropathy?

Classic distal symmetric polyneuropathy is characterized by sensory disturbances with the following distribution:

maximum severity in the distal segments, especially the digits of the extremities;
gradual proximal attenuation;
a 'stocking-and-glove' distribution pattern;
impairments develop significantly more often and earlier in the lower extremities.

Numbness, decreased sensation in the hands and feet, and gait instability (sensory ataxia) are also characteristic of polyneuropathic involvement.

What is the role of the polyol pathway in the development of the disease?

During hyperglycemia, the enzyme aldose reductase is activated within neurons and Schwann cells. It initiates the conversion of excess glucose into sorbitol, the accumulation of which leads to structural damage of neural tissue.

Why might patients with diabetes faint when standing up?

This is a manifestation of autonomic neuropathy, which impairs the neurogenic regulation of vascular tone. Postural hypotensive reactions occur—an acute drop in blood pressure when transitioning from lying or sitting to a vertical position.

What constitutes the autoimmune component of the pathogenesis?

Due to excessive glycosylation, peripheral nerve proteins alter their structure. The body begins to produce immunoglobulins against these modified proteins, triggering an autoimmune attack against native neural tissue antigens.

How do diabetic mononeuropathies manifest clinically?

They present as transient flaccid paralyses of the hands and feet due to proximal motor neuron involvement. Reversible paresis of the III, IV, or VI cranial nerves is also characteristic.

Go deeper

Biochemical mechanisms of excessive glycosylation of peripheral nerve proteins
Role of aldose reductase and the polyol pathway in Schwann cell damage
Autoimmune aggression against neural tissue antigens: triggers and consequences
Pathogenesis of reduced intraneural blood flow and chronic ischemia
Mechanisms of impaired neurogenic cardiac regulation and the risk of sudden death
Differential diagnosis of diabetic radiculopathies and mononeuropathies